Literature DB >> 15194765

Murine cytomegalovirus with a transposon insertional mutation at open reading frame m155 is deficient in growth and virulence in mice.

Gerardo Abenes1, Karen Chan, Manfred Lee, Erik Haghjoo, Jiaming Zhu, Tianhong Zhou, Xiaoyan Zhan, Fenyong Liu.   

Abstract

A pool of murine cytomegalovirus (MCMV) mutants was previously generated by using a Tn3-based transposon mutagenesis approach (X. Zhan, M. Lee, J. Xiao, and F. Liu, J. Virol. 74:7411-7421, 2000). In this study, one of the MCMV mutants, Rvm155, which contained the transposon insertion in open reading frame m155, was characterized in vitro for its replication in tissue culture and in vivo for its growth and virulence in immunodeficient SCID mice. Compared to the wild-type strain and a rescued virus that restored the m155 region, the mutant is significantly deficient in growth in many organs of the infected animals. At 21 days postinfection the titers of Rvm155 in the salivary glands, lungs, spleens, livers, and kidneys of the intraperitoneally infected SCID mice were lower than the titers of the wild-type virus and the rescued virus by 50-, 1,000-, 500-, 100-, and 500-fold, respectively. Moreover, the viral mutant was attenuated in killing the SCID mice, as none of the SCID mice that were intraperitoneally infected with Rvm155 died until 38 days postinfection while all the animals infected with the wild-type and rescued viruses died at 27 days postinfection. Our results provide the first direct evidence that a disruption of m155 expression leads to attenuation of viral virulence and growth in animals. Moreover, these results suggest that m155 is a viral determinant for optimal MCMV growth and virulence in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194765      PMCID: PMC421665          DOI: 10.1128/JVI.78.13.6891-6899.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate.

Authors:  F Y Liu; B Roizman
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

2.  Regeneration of herpesviruses from molecularly cloned subgenomic fragments.

Authors:  M van Zijl; W Quint; J Briaire; T de Rover; A Gielkens; A Berns
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

3.  Epstein-Barr virus recombinants from overlapping cosmid fragments.

Authors:  B Tomkinson; E Robertson; R Yalamanchili; R Longnecker; E Kieff
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

4.  The efficacy of biological response modifiers against murine cytomegalovirus infection in normal and immunodeficient mice.

Authors:  M Okada; Y Minamishima
Journal:  Microbiol Immunol       Date:  1987       Impact factor: 1.955

5.  Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Authors:  J E Gallant; R D Moore; D D Richman; J Keruly; R E Chaisson
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

6.  Experimental murine cytomegalovirus infection in severe combined immunodeficient mice.

Authors:  R P Reynolds; R J Rahija; D I Schenkman; C B Richter
Journal:  Lab Anim Sci       Date:  1993-08

7.  Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro.

Authors:  J I Cohen; K E Seidel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

8.  Characterization of a strain of murine cytomegalovirus which fails to grow in the salivary glands of mice.

Authors:  J M Boname; J K Chantler
Journal:  J Gen Virol       Date:  1992-08       Impact factor: 3.891

9.  Identification and characterization of a murine cytomegalovirus gene with homology to the UL25 open reading frame of human cytomegalovirus.

Authors:  P B Dallas; P A Lyons; J B Hudson; A A Scalzo; G R Shellam
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

10.  Cytomegalovirus determinant of replication in salivary glands.

Authors:  W C Manning; C A Stoddart; L A Lagenaur; G B Abenes; E S Mocarski
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

View more
  12 in total

1.  The mouse cytomegalovirus glycoprotein m155 inhibits CD40 expression and restricts CD4 T cell responses.

Authors:  Andrea I Loewendorf; Lars Steinbrueck; Christoph Peter; Andreas Busche; Chris A Benedict; Penelope C Kay-Jackson
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

2.  Characterization of the murine cytomegalovirus m136 gene.

Authors:  Robert J Visalli; Denise M Nicolosi; Karen Irven; Tamseel Khan; Melissa A Visalli
Journal:  Virus Genes       Date:  2006-12-02       Impact factor: 2.332

3.  Effective inhibition of cytomegalovirus infection by external guide sequences in mice.

Authors:  Xiaohong Jiang; Hao Gong; Yuan-Chuan Chen; Gia-Phong Vu; Phong Trang; Chen-Yu Zhang; Sangwei Lu; Fenyong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

4.  Murine cytomegalovirus encodes a stable intron that facilitates persistent replication in the mouse.

Authors:  Caroline A Kulesza; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-14       Impact factor: 11.205

5.  Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.

Authors:  Milena Hasan; Astrid Krmpotic; Zsolt Ruzsics; Ivan Bubic; Tihana Lenac; Anne Halenius; Andrea Loewendorf; Martin Messerle; Hartmut Hengel; Stipan Jonjic; Ulrich H Koszinowski
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice.

Authors:  Yong Bai; Hao Gong; Hongjian Li; Gia-Phong Vu; Sangwei Lu; Fenyong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

7.  Effective inhibition in animals of viral pathogenesis by a ribozyme derived from RNase P catalytic RNA.

Authors:  Yong Bai; Phong Trang; Hongjian Li; Kihoon Kim; Tianhong Zhou; Fenyong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-28       Impact factor: 11.205

8.  Feeling manipulated: cytomegalovirus immune manipulation.

Authors:  Mindy Miller-Kittrell; Tim E Sparer
Journal:  Virol J       Date:  2009-01-09       Impact factor: 4.099

9.  Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18.

Authors:  Cora Griffin; Eddie C Y Wang; Brian P McSharry; Carole Rickards; Helena Browne; Gavin W G Wilkinson; Peter Tomasec
Journal:  J Gen Virol       Date:  2005-11       Impact factor: 3.891

10.  The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.

Authors:  Melissa B Lodoen; Gerardo Abenes; Sean Umamoto; Jeffrey P Houchins; Fenyong Liu; Lewis L Lanier
Journal:  J Exp Med       Date:  2004-10-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.